The normobaric oxygen paradox: A novel way to administer oxygen as an adjuvant treatment for cancer?

被引:34
作者
De Bels, D. [1 ,3 ]
Corazza, F. [2 ]
Germonpre, P. [3 ,4 ]
Balestra, C. [3 ]
机构
[1] Brugmann Univ Hosp, Intens Care Unit, Dept Intens Care, B-1030 Brussels, Belgium
[2] Brugmann Univ Hosp, Immunol Lab, B-1030 Brussels, Belgium
[3] Haute Ecole Paul Henri Spaak, Environm & Occupat Physiol Lab, Brussels, Belgium
[4] Queen Astrid Mil Hosp, Hyperbar Ctr, Brussels, Belgium
关键词
CHEMOTHERAPY; ANEMIA; GLUTATHIONE; MANAGEMENT; CELLS; EPO;
D O I
10.1016/j.mehy.2010.11.022
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The "normobaric oxygen paradox" is a dual mechanism by which oxygen regulates the expression of the Hypoxia Inducible Factor 1 alpha (HIF-1 alpha). The HIF-1 alpha-depending gene regulation is responsible for many different genetic expressions including EPO and VEGF that are usually expressed in parallel. First, VEGF under-expression could decrease tumor angiogenesis leading to a decrease in tumor growth or even apoptosis of cancer cells. Second, induction of EPO-expression can provide cytoprotection. Altogether, this could be deleterious for cancer cells while helping non-malignant cells (at least neural and cardiac) cells to be protected from the side effects of chemotherapy. Eventually, HIF induction could boost immune response by inflammatory cells, increasing their antitumor activity. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:467 / 470
页数:4
相关论文
共 15 条
[1]   Hypoxia inducible factor stabilization leads to lasting improvement of hippocampal memory in healthy mice [J].
Adamcio, Bartosz ;
Sperling, Swetlana ;
Hagemeyer, Nora ;
Walkinshaw, Gail ;
Ehrenreich, Hannelore .
BEHAVIOURAL BRAIN RESEARCH, 2010, 208 (01) :80-84
[2]   The role of glutathione in cancer [J].
Balendiran, GK ;
Dabur, R ;
Fraser, D .
CELL BIOCHEMISTRY AND FUNCTION, 2004, 22 (06) :343-352
[3]   Serum erythropoietin levels in healthy humans after a short period of normobaric and hyperbaric oxygen breathing:: the "normobaric oxygen paradox" [J].
Balestra, C ;
Germonpré, P ;
Poortmans, JR ;
Marroni, A .
JOURNAL OF APPLIED PHYSIOLOGY, 2006, 100 (02) :512-518
[4]   Anti-Epo receptor antibodies do not predict Epo receptor expression [J].
Elliott, S ;
Busse, L ;
Bass, MB ;
Lu, H ;
Sarosi, I ;
Sinclair, AM ;
Spahr, C ;
Um, M ;
Van, G ;
Begley, CG .
BLOOD, 2006, 107 (05) :1892-1895
[5]   Glutathione in cancer biology and therapy [J].
Estrela, JM ;
Ortega, A ;
Obrador, E .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2006, 43 (02) :143-181
[6]   EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells [J].
Hart, C. ;
Grassinger, J. ;
Andreesen, R. ;
Hennemann, B. .
BONE MARROW TRANSPLANTATION, 2009, 43 (03) :197-206
[7]   Erythropoietin receptors on cancer cells: exciting perspectives, difficult to appreciate [J].
Henke, Michael ;
Verma, Ajay ;
Acs, Gaza .
BLOOD, 2006, 108 (03) :1107-1108
[8]  
Huang Jinlian, 2010, CANCER BIOL THER, P9
[9]   Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1α [J].
Koukourakis, MI ;
Giatromanolaki, A ;
Chong, W ;
Simopoulos, C ;
Polychronidis, A ;
Sivridis, E ;
Harris, AL .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (01) :8-14
[10]   Overcoming the Drug Resistance in Breast Cancer Cells by Rational Design of Efficient Glutathione S-Transferase Inhibitors [J].
Li, Wen-Shan ;
Lam, Wing See ;
Liu, Kung-Cheng ;
Wang, Chie-Hong ;
Chang, Hui Chuan ;
Jen, Ya Ching ;
Hsu, Yu-Ting ;
Shivatare, Sachin S. ;
Jao, Shu-Chuan .
ORGANIC LETTERS, 2010, 12 (01) :20-23